7,880
Views
114
CrossRef citations to date
0
Altmetric
Research Article

Polydopamine and peptide decorated doxorubicin-loaded mesoporous silica nanoparticles as a targeted drug delivery system for bladder cancer therapy

, , , , , , & show all
Pages 681-691 | Received 28 Jan 2017, Accepted 17 Mar 2017, Published online: 17 Apr 2017

References

  • Abd-Elrahman AA, El Nabarawi MA, Hassan DH, Taha AA. (2016). Ketoprofen mesoporous silica nanoparticles SBA-15 hard gelatin capsules: preparation and in vitro/in vivo characterization. Drug Deliv 23:3387–98.
  • Acharya S, Sahoo SK. (2011). PLGA nanoparticles containing various anticancer agents and tumour delivery by EPR effect. Adv Drug Deliv Rev 63:170–83.
  • Ahmadi E, Dehghannejad N, Hashemikia S, et al. (2014). Synthesis and surface modification of mesoporous silica nanoparticles and its application as carriers for sustained drug delivery. Drug Deliv 21:164–72.
  • Attia ABE, Oh P, Yang C, et al. (2014). Insights into EPR effect versus lectin-mediated targeted delivery: biodegradable polycarbonate micellar nanoparticles with and without galactose surface decoration. Small 10:4281–6.
  • Beik J, Abed Z, Ghoreishi FS, et al. (2016). Nanotechnology in hyperthermia cancer therapy: from fundamental principles to advanced applications. J Control Release 235:205–21.
  • Bernsmann F, Ponche A, Ringwald C, et al. (2009). Characterization of dopamine-melanin growth on silicon oxide. J Phys Chem C 113:8234–42.
  • Cao W, Zeng XW, Liu G, et al. (2015). Porphine functionalized nanoparticles of star-shaped poly(epsilon-caprolactone)-b-d-alpha-tocopheryl polyethylene glycol 1000 succinate biodegradable copolymer for chemophotodynamic therapy on cervical cancer. Acta Biomater 26:145–58.
  • Chang DF, Gao YF, Wang LJ, et al. (2016). Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy. J Colloid Interface Sci 463:279–87.
  • Cho S, Kim SH. (2015). Hydroxide ion-mediated synthesis of monodisperse dopamine-melanin nanospheres. J Colloid Interface Sci 458:87–93.
  • Das P, Jana NR. (2015). Dopamine functionalized polymeric nanoparticle for targeted drug delivery. RSC Adv 5:33586–94.
  • de Oliveira LF, Bouchmella K, Goncalves Kde A, et al. (2016). Functionalized silica nanoparticles as an alternative platform for targeted drug-delivery of water insoluble drugs. Langmuir 32:3217–25.
  • Dinney CPN, McConkey DJ, Millikan RE, et al. (2004). Focus on bladder cancer. Cancer Cell 6:111–6.
  • Gao NS, Chen ZH, Xiao XJ, et al. (2015). Surface modification of paclitaxel-loaded tri-block copolymer PLGA-b-PEG-b-PLGA nanoparticles with protamine for liver cancer therapy. J Nanopart Res 17:347. doi: 10.1007/s11051-015-3121-3
  • Gao YH, Yang CH, Liu X, et al. (2012). A multifunctional nanocarrier based on nanogated mesoporous silica for enhanced tumor-specific uptake and intracellular delivery. Macromol Biosci 12:251–9.
  • Gu J, Wang T, Fan G, et al. (2016). Biocompatibility of artificial bone based on vancomycin loaded mesoporous silica nanoparticles and calcium sulfate composites. J Mater Sci Mater Med 27:64
  • Habibi S, Nematollahzadeh A, Mousavi SA. (2015). Nano-scale modification of polysulfone membrane matrix and the surface for the separation of chromium ions from water. Chem Eng J 267:306–16.
  • Hashemikia S, Hemmatinejad N, Ahmadi E, Montazer M. (2016). Antibacterial and anti-inflammatory drug delivery properties on cotton fabric using betamethasone-loaded mesoporous silica particles stabilized with chitosan and silicone softener. Drug Deliv 23:2946–55.
  • Hu CM, Cui WG. (2012). Hierarchical structure of electrospun composite fibers for long-term controlled drug release carriers. Adv Healthc Mater 1:809–14.
  • Hu M, Jacobs BL, Montgomery JS, et al. (2014). Sharpening the focus on causes and timing of readmission after radical cystectomy for bladder cancer. Cancer 120:1409–16.
  • Jaiswal MK, Pradhan L, Vasavada S, et al. (2015). Magneto-thermally responsive hydrogels for bladder cancer treatment: therapeutic efficacy and in vivo biodistribution. Colloid Surf B 136:625–33.
  • Jia XY, Yu Q, Zhang ZH, Yang XF. (2012). Targeting bladder tumor cells in voided urine of Chinese patients with FITC-CSNRDARRC peptide ligand. OncoTargets Ther 5:85–90.
  • Jiang J, Zhu L, Zhu B, Xu Y. (2011). Surface characteristics of a self-polymerized dopamine coating deposited on hydrophobic polymer films. Langmuir 27:14180–7.
  • Jiao YF, Shen S, Sun YF, et al. (2015). A functionalized hollow mesoporous silica nanoparticles-based controlled dual-drug delivery system for improved tumor cell cytotoxicity. Part Part Syst Char 32:222–33.
  • Jung HK, Kim S, Park RW, et al. (2016). Bladder tumor-targeted delivery of pro-apoptotic peptide for cancer therapy. J Control Release 235:259–67.
  • Key J, Dhawan D, Cooper CL, et al. (2016). Multicomponent, peptide-targeted glycol chitosan nanoparticles containing ferrimagnetic iron oxide nanocubes for bladder cancer multimodal imaging. Int J Nanomed 11:4141–55.
  • Lee H, Dellatore SM, Miller WM, Messersmith PB. (2007a). Mussel-inspired surface chemistry for multifunctional coatings. Science 318:426–30.
  • Lee H, Rho J, Messersmith PB. (2009). Facile conjugation of biomolecules onto surfaces via mussel adhesive protein inspired coatings. Adv Mater 21:431–4.
  • Lee SM, Lee EJ, Hong HY, et al. (2007b). Targeting bladder tumor cells in vivo and in the urine with a peptide identified by phage display. Mol Cancer Res 5:11–19.
  • Lian DZ, Chen YH, Xu G, et al. (2016). Delivery of siRNA targeting HIF-1 alpha loaded chitosan modified d-alpha-tocopheryl polyethylene glycol 1000 succinate-b-poly(epsilon-caprolactone-ran-glycolide) nanoparticles into nasopharyngeal carcinoma cell to improve the therapeutic efficacy of cisplatin. RSC Adv 6:37740–9.
  • Liu Q, Wang NY, Caro J, Huang AS. (2013). Bio-inspired polydopamine: a versatile and powerful platform for covalent synthesis of molecular sieve membranes. J Am Chem Soc 135:17679–82.
  • Loureiro JA, Gomes B, Fricker G, et al. (2016). Cellular uptake of PLGA nanoparticles targeted with anti-amyloid and anti-transferrin receptor antibodies for Alzheimer's disease treatment. Colloids Surf B Biointerfaces 145:8–13.
  • Luo GF, Chen WH, Liu Y, et al. (2014). Multifunctional enveloped mesoporous silica nanoparticles for subcellular co-delivery of drug and therapeutic peptide. Sci Rep 4:6064.
  • Maggini L, Cabrera I, Ruiz-Carretero A, et al. (2016). Breakable mesoporous silica nanoparticles for targeted drug delivery. Nanoscale 8:7240–7.
  • Mariam J, Sivakami S, Dongre PM. (2016). Albumin corona on nanoparticles – a strategic approach in drug delivery. Drug Deliv 23:2668–76.
  • Meng H, Li YT, Faust M, et al. (2015). Hydrogen peroxide generation and biocompatibility of hydrogel-bound mussel adhesive moiety. Acta Biomater 17:160–9.
  • Nematollahzadeh A, Shojaei A, Abdekhodaie MJ, Sellergren B. (2013). Molecularly imprinted polydopamine nano-layer on the pore surface of porous particles for protein capture in HPLC column. J Colloid Interface Sci 404:117–26.
  • Niedermayer S, Weiss V, Herrmann A, et al. (2015). Multifunctional polymer-capped mesoporous silica nanoparticles for pH-responsive targeted drug delivery. Nanoscale 7:7953–64.
  • Niemela E, Desai D, Nkizinkiko Y, et al. (2015). Sugar-decorated mesoporous silica nanoparticles as delivery vehicles for the poorly soluble drug celastrol enables targeted induction of apoptosis in cancer cells. Eur J Pharm Biopharm 96:11–21.
  • Park J, Brust TF, Lee HJ, et al. (2014). Polydopamine-based simple and versatile surface modification of polymeric nano drug carriers. ACS Nano 8:3347–56.
  • Pranatharthiharan S, Patel MD, Malshe VC, Devarajan PV. (2016). Polyethylene sebacate doxorubicin nanoparticles: role of carbohydrate anchoring on in vitro and in vivo anticancer efficacy. Drug Deliv 23:2980–9.
  • Ru G, Han L, Qing J, et al. (2016). Effects of borneol on the pharmacokinetics of 9-nitrocamptothecin encapsulated in PLGA nanoparticles with different size via oral administration. Drug Deliv 23:3417–23.
  • Scott AR. (2015). Polymers: secrets from the deep sea. Nature 519:S12–3.
  • Tao W, Zeng X, Wu J, et al. (2016). Polydopamine-based surface modification of novel nanoparticle-aptamer bioconjugates for in vivo breast cancer targeting and enhanced therapeutic effects. Theranostics 6:470–84.
  • Tao W, Zhang JX, Zeng XW, et al. (2015). Blended nanoparticle system based on miscible structurally similar polymers: a safe, simple, targeted, and surprisingly high efficiency vehicle for cancer therapy. Adv Healthc Mater 4:1203–14.
  • Tummala S, Gowthamarajan K, Satish Kumar MN, Wadhwani A. (2016). Oxaliplatin immuno hybrid nanoparticles for active targeting: an approach for enhanced apoptotic activity and drug delivery to colorectal tumors. Drug Deliv 23:1773–87.
  • Ulbrich K, Hola K, Subr V, et al. (2016). Targeted drug delivery with polymers and magnetic nanoparticles: covalent and noncovalent approaches, release control, and clinical studies. Chem Rev 116:5338–431.
  • Wang H, Jia Y, Hu W, et al. (2013). Effect of preparation conditions on the size and encapsulation properties of mPEG-PLGA nanoparticles simultaneously loaded with vincristine sulfate and curcumin. Pharm Dev Technol 18:694–700.
  • Wang K, Purushotham S, Lee JY, et al. (2010). In vivo imaging of tumor apoptosis using histone H1-targeting peptide. J Control Release 148:283–91.
  • Wang T, Zhu DW, Liu G, et al. (2015a). DTX-loaded star-shaped TAPP-PLA-b-TPGS nanoparticles for cancer chemical and photodynamic combination therapy. RSC Adv 5:50617–27.
  • Wang Y, Zhao Q, Han N, et al. (2015b). Mesoporous silica nanoparticles in drug delivery and biomedical applications. Nanomedicine-Uk 11:313–27.
  • Wu S, Yang X, Lu Y, et al. (2017). A green approach to dual-drug nanoformulations with targeting and synergistic effects for cancer therapy. Drug Deliv 24:51–60.
  • Xiao XJ, Zeng XW, Zhang XX, et al. (2013). Effects of Caryota mitis profilin-loaded PLGA nanoparticles in a murine model of allergic asthma. Int J Nanomed 8:4553–62.
  • Zeng XW, Tao W, Mei L, et al. (2013). Cholic acid-functionalized nanoparticles of star-shaped PLGA-vitamin E TPGS copolymer for docetaxel delivery to cervical cancer. Biomaterials 34:6058–67.
  • Zhang HL, Liu G, Zeng XW, et al. (2015a). Fabrication of genistein-loaded biodegradable TPGS-b-PCL nanoparticles for improved therapeutic effects in cervical cancer cells. Int J Nanomed 10:2461–73.
  • Zhang J, Tao W, Chen Y, et al. (2015b). Doxorubicin-loaded star-shaped copolymer PLGA-vitamin E TPGS nanoparticles for lung cancer therapy. J Mater Sci Mater Med 26:165
  • Zheng C, Xu J, Yao XP, et al. (2011). Polyphosphazene nanoparticles for cytoplasmic release of doxorubicin with improved cytotoxicity against Dox-resistant tumor cells. J Colloid Interface Sci 355:374–82.
  • Zheng MB, Yue CX, Ma YF, et al. (2013). Single-step assembly of DOX/ICG loaded lipid-polymer nanoparticles for highly effective chemo-photothermal combination therapy. ACS Nano 7:2056–67.
  • Zheng QS, Lin TR, Wu HY, et al. (2014). Mussel-inspired polydopamine coated mesoporous silica nanoparticles as pH-sensitive nanocarriers for controlled release. Int J Pharmaceut 463:22–6.
  • Zhou DH, Zhang G, Gan ZH. (2013). c(RGDfK) decorated micellar drug delivery system for intravesical instilled chemotherapy of superficial bladder cancer. J Control Release 169:204–10.
  • Zhu DW, Tao W, Zhang HL, et al. (2016). Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer. Acta Biomater 30:144–54.
  • Zhu HJ, Chen HB, Zeng XW, et al. (2014). Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance. Biomaterials 35:2391–400.